Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.7 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |